$BPMX our goal is to announce a strategic partnership transaction to advance our late-stage topical minocycline drug candidates in Q4 2019, which should contribute to regaining compliance.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.